EVH Evolent Health Inc

Price (delayed)

$28.8

Market cap

$3.24B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.38

Enterprise value

$3.78B

Evolent Health delivers proven clinical and administrative solutions that improve whole-person health while making health care simpler and more affordable. Its solutions encompass total cost of care management, specialty care ...

Highlights
The company's equity has surged by 84% YoY and by 31% QoQ
The revenue has grown by 50% YoY and by 10% from the previous quarter
The EPS has shrunk by 90% QoQ but it rose by 2.6% YoY
The gross margin has contracted by 12% YoY but it has grown by 2.6% from the previous quarter
The debt has soared by 100% YoY and by 45% QoQ
Evolent Health's net income has shrunk by 76% QoQ

Key stats

What are the main financial stats of EVH
Market
Shares outstanding
112.67M
Market cap
$3.24B
Enterprise value
$3.78B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.85
Price to sales (P/S)
2.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.55
Earnings
Revenue
$1.48B
EBIT
-$120.34M
EBITDA
-$38.97M
Free cash flow
-$993,000
Per share
EPS
-$0.38
Free cash flow per share
-$0.01
Book value per share
$10.1
Revenue per share
$13.76
TBVPS
$5.99
Balance sheet
Total assets
$2.59B
Total liabilities
$1.3B
Debt
$691.16M
Equity
$1.12B
Working capital
$18.32M
Liquidity
Debt to equity
0.62
Current ratio
1.04
Quick ratio
0.97
Net debt/EBITDA
-13.69
Margins
EBITDA margin
-2.6%
Gross margin
24%
Net margin
-2.3%
Operating margin
-1.7%
Efficiency
Return on assets
-2.1%
Return on equity
-4.6%
Return on invested capital
-22.1%
Return on capital employed
-5.6%
Return on sales
-8.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
-1%
1 week
-12.46%
1 month
-18.23%
1 year
1.37%
YTD
2.56%
QTD
-11.25%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$1.48B
Gross profit
$356.48M
Operating income
-$24.95M
Net income
-$33.8M
Gross margin
24%
Net margin
-2.3%
The company's operating income has shrunk by 168% YoY and by 25% QoQ
The operating margin has plunged by 89% YoY and by 13% from the previous quarter
Evolent Health's net income has shrunk by 76% QoQ
The net margin has shrunk by 64% QoQ but it has increased by 30% YoY

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
2.85
P/S
2.09
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.55
The EPS has shrunk by 90% QoQ but it rose by 2.6% YoY
The company's equity has surged by 84% YoY and by 31% QoQ
EVH's price to book (P/B) is 23% lower than its last 4 quarters average of 3.7 but 19% higher than its 5-year quarterly average of 2.4
The revenue has grown by 50% YoY and by 10% from the previous quarter
The price to sales (P/S) is 13% lower than the last 4 quarters average of 2.4 but 4.5% higher than the 5-year quarterly average of 2.0

Efficiency

How efficient is Evolent Health business performance
The ROS has shrunk by 131% QoQ
EVH's return on invested capital has dropped by 117% since the previous quarter
The ROE has plunged by 77% from the previous quarter but it has grown by 12% YoY
Evolent Health's return on assets has shrunk by 75% QoQ but it has increased by 16% YoY

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 100% higher than its total liabilities
The company's total assets has surged by 93% YoY and by 42% QoQ
The total liabilities has soared by 78% YoY and by 35% from the previous quarter
The debt is 38% lower than the equity
The debt has soared by 100% YoY and by 45% QoQ
The company's equity has surged by 84% YoY and by 31% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.